2. Signaling Pathways
  3. Metabolic Enzyme/Protease
  4. MAGL
  5. MAGL Antagonist

MAGL Antagonist

MAGL Antagonists (2):

Cat. No. Product Name Effect Purity
  • HY-158339
    ABHD antagonist 2
    		Antagonist
    ABHD antagonist 2 (Compound 9) is an antagonist for alpha/beta-Hydrolase domain containing 6 (ABHD6), with IC50 <0.001 μM. ABHD antagonist 2 exhibits good binding ability with ABHD6, with IC50 of 0.002 μM.
  • HY-158338
    ABHD antagonist 1
    		Antagonist
    ABHD antagonist 1 possesses ABHD6 (α/β-Hydrolase domain containing 6) inhibitory activity, involving the regulation of biochemical pathways involved in ABHD6, thereby affecting cell function and inflammatory response. ABHD antagonist 1 can be used in pain, neuropathic diseases, inflammatory diseases. Autoimmune diseases, metabolic diseases, and cancer research.